This review will use the term MASLD, defined as the presence of hepatic steatosis with no other discernible cause, in conjunction with at least one cardiometabolic risk factor (CMRF), such as type 2 diabetes mellitus (T2DM), obesity, hypertension, or dyslipidemia
Some animal studies show curcumin may improve blood sugar control by increasing GLP-1 release
doi: 10.1016/j.cmet.2017.04.013 69 MoreiraGAzevedoFRibeiroLSantosAGuadagniniDGamaPet al
Nannipieri M, Baldi S, Mari A, Colligiani D, Guarino D, Camastra S, et al
The most recently approved type, tirzepatide [archived link], is called a dual agonist because it mimics the effects of two gut hormones, GLP-1 and GIP (glucose-dependent insulinotropic polypeptide)
News provided by Accolade Oct 09, 2023, 09:00 ET Employer survey: 25% of employers currently offer coverage and most experience positive outcomes